ABIVAX SA (2X1.DE) Forecast, Price Target & Analyst Ratings
FRA:2X1 • FR0012333284
94.3 EUR
+0.1 (+0.11%)
Last: Mar 9, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ABIVAX SA (2X1.DE).
Forecast Snapshot
Consensus Price Target
€128.03
+ 35.77% Upside
Next Earnings Forecast
Release DateMar 23, 2026
PeriodQ4 / 2025
EPS Estimate-€1.52
Revenue Estimate2.04M
ChartMill Buy Consensus
85.71%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€128.03
Upside
+ 35.77%
From current price of €94.30 to mean target of €128.03, Based on 14 analyst forecasts
Low
€63.51
Median
€136.43
High
€178.18
Price Target Revisions
1 Month
0.03%
3 Months
21.66%
Price Target Summary
14 analysts have analysed 2X1.DE and the average price target is 128.03 EUR. This implies a price increase of 35.77% is expected in the next year compared to the current price of 94.3.
The average price target has been revised upward by 21.66% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.71%
2X1.DE was analyzed by 14 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about 2X1.DE.
In the previous month the buy percentage consensus was at a similar level.
2X1.DE was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 23, 2026
PeriodQ4 / 2025
EPS Estimate-€1.52
Revenue Estimate2.04M
Revenue Q2Q-63.79%
EPS Q2Q-1.66%
Number of Analysts4
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
2X1.DE is expected to report earnings on 3/23/2026. The consensus EPS estimate for the next earnings is -1.52 EUR and the consensus revenue estimate is 2.04M EUR.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 0.22% | N/A 3,694.18% | N/A 50.46% | N/A 99.66% | N/A 52.13% | N/A 29.34% | N/A 42.23% | N/A 15.91% | |||||||||||
| EBITDA YoY % growth | -18.119M | N/A 66.28% | -14.057M -130.05% | -19.037M -35.43% | -33.216M -74.48% | -37.942M -14.23% | -42.404M -11.76% | -50.719M -19.61% | -126.669M -149.75% | -171.884M -35.70% | N/A -25.11% | N/A -10.20% | N/A 71.55% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -18.255M | -18.236M 0.10% | -14.15M 22.41% | -19.108M -35.04% | -33.296M -74.25% | -38.008M -14.15% | -42.56M -11.98% | -51.204M -20.31% | -127.376M -148.76% | -172.984M -35.81% | N/A -21.03% | N/A -6.52% | N/A 52.40% | N/A 184.62% | N/A 301.34% | N/A 102.11% | N/A 51.79% | N/A 61.39% | N/A 18.10% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A 81.03% | N/A -178.79% | N/A -88.59% | N/A -32.95% | N/A -11.97% | N/A 173.61% | N/A -259.69% | N/A 19.63% | N/A -6.86% | N/A -20.70% | N/A 81.52% | N/A -363.61% | N/A | N/A | N/A 26.18% | N/A 83.69% | N/A | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -1.52 -1.66% |
| Revenue Q2Q % growth | 2.04M -63.79% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -100.827M -8.43% |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-1.13%
EPS Next 5 Year
-8.10%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
266.42%
Revenue Next 5 Year
171.60%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
16.00%
EBIT Next 5 Year
N/A
ABIVAX SA / 2X1.DE Forecast FAQ
What is the average price target for ABIVAX SA (2X1.DE) stock?
14 analysts have analysed 2X1.DE and the average price target is 128.03 EUR. This implies a price increase of 35.77% is expected in the next year compared to the current price of 94.3.
When does ABIVAX SA (2X1.DE) report earnings?
ABIVAX SA (2X1.DE) will report earnings on 2026-03-23, after the market close.
What are the consensus estimates for 2X1 stock next earnings?
The consensus EPS estimate for the next earnings of ABIVAX SA (2X1.DE) is -1.52 EUR and the consensus revenue estimate is 2.04M EUR.
What is the consensus rating for ABIVAX SA (2X1.DE) stock?
The consensus rating for ABIVAX SA (2X1.DE) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.